Abiopharma

Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering

Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering

22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026

Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors

Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research

Western Asset High Income Fund II Inc. Announces Financial Position as of January 31, 2026

February’s $30M+ Home Sales Cluster in Florida and NYC—Including Two in the Same Barrier Island Enclave

PROJECT HAIL MARY Posts Biggest Opening Weekend of 2026 at AMC Theatres®; AMC Records Its Second-Highest Weekend of the Year for Admissions Revenue in the U.S. and Globally

MIMEDX Announces Launch of CHORIOFIX™

Ormat Technologies, Inc. Announces Closing of Upsized $1 Billion Convertible Senior Notes Offering